Results 21 to 30 of about 6,304 (197)

Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial. [PDF]

BMJ Open
Introduction Seasonal malaria chemoprevention (SMC) involves repeated administrations of sulfadoxine-pyrimethamine plus amodiaquine to children below the age of 5 years during the peak transmission season in areas of seasonal malaria transmission.
Moreno M, Barry A, Gmeiner M, Yaro JB, Sermé SS, Byrne I, Ramjith J, Ouedraogo A, Soulama I, Grignard L, Soremekun S, Koele S, Ter Heine R, Ouedraogo AZ, Sawadogo J, Sanogo E, Ouedraogo IN, Hien D, Sirima SB, Bradley J, Bousema T, Drakeley C, Tiono AB.   +22 more
europepmc   +4 more sources

A cost analysis comparing seasonal malaria chemoprevention with and without Vitamin A supplementation among under-5 children in Nigeria. [PDF]

PLoS One
Oresanya OB, Arije O, Fadipe J, Rotimi K, Phillips A, Maxwell K, Shekarau E, Onwu N, Bazant ES.   +8 more
europepmc   +3 more sources

Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger [PDF]

Malaria Journal, 2021
Background In endemic areas, children develop slowly and naturally anti-Plasmodium antibodies and become semi-immune. Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine + amodiaquine (SPAQ) is a new strategy to reduce malaria morbidity
Lamine Mahaman Moustapha, Rafiou Adamou, Maman Laminou Ibrahim, Mariama Abdoulaye Louis Padounou, Abdoulaye Diallo, David Courtin, Jean Testa, Jean Louis Abdourahim Ndiaye   +7 more
doaj   +2 more sources

Seasonal malaria chemoprevention: drug design and selection

The Lancet Global Health
Issaka Zongo, Yves Daniel Compaoré
semanticscholar   +4 more sources

Evaluation of seasonal malaria chemoprevention implementation in the Upper East region of Northern Ghana. [PDF]

Malar J
Ghana adopted the WHO-recommended Seasonal Malaria Chemoprevention (SMC) in 2016 following a pilot study as a vital strategy for malaria control. SMC is the intermittent administration of a preventive and curative dose of anti-malarial medicine (Sulfadoxine-Pyrimetamine + Amodiaquine) during four months of the malaria season.
Ayamba EY, Dzotsi EK, Dormechele W, Ansah NA, Bangre O, Nyuzaghl JA, Abilba SA, Boakye-Boateng SK, Ansah PO.   +8 more
europepmc   +5 more sources

Seasonal Malaria Chemoprevention: An Evolving Research Paradigm. [PDF]

PLoS Medicine, 2016
Robert W. Snow discusses the importance of empirical evidence, such as that provided in the trial published this week by Milligan and colleagues, in guiding malaria control in Africa.
Robert W Snow
doaj   +4 more sources

Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: a qualitative exploration of caregivers and community distributors' perspectives. [PDF]

Malar J
Background Recommended since 2012 by the World Health Organization (WHO), seasonal malaria chemoprevention (SMC) is a community-based intervention to prevent malaria in children in African regions where malaria transmission follows a seasonal pattern ...
Lasmi K, Elimian K, Donovan L, Tounaikok N, Traoré A, Gils T, Rassi C, Marasciulo M, Richardson S, Tougri G, Diar MSI, Baker K.   +11 more
europepmc   +2 more sources

Adaptation of lot quality assurance sampling to monitor seasonal malaria chemoprevention delivery performance. [PDF]

Trans R Soc Trop Med Hyg
Malaria Consortium supports delivery of seasonal malaria chemoprevention (SMC) to children ages 3–59 months using sulfadoxine–pyrimethamine plus amodiaquine.
Richardson S, Ibinaiye T, Oresanya O, Oguoma C, Okoronkwo C, Shekarau E, Sprague D, Baker K, de Cola MA, Roca-Feltrer A, Nnaji C, Rassi C.   +11 more
europepmc   +2 more sources

Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3–59 months in Nigeria: A propensity score‐matched analysis

Tropical Medicine &International Health, Volume 29, Issue 8, Page 668-679, August 2024.
Seasonal malaria chemoprevention using sulfadoxine‐pyrimethamine plus amodiaquine (sulfadoxine‐pyrimethamine plus amodiaquine on Day 1 and amodiaquine on both Day 2 and Day 3) is delivered to children aged 3–59 months in areas of highly season malaria ...
Sikai Huang, Kevin Baker, Taiwo Ibinaiye, O. Oresanya, Chuks Nnaji, S. Richardson   +5 more
semanticscholar   +2 more sources

Malaria trends in districts that were targeted and not-targeted for seasonal malaria chemoprevention in children under 5 years of age in Guinea, 2014-2021. [PDF]

BMJ Glob Health
Background Seasonal malaria chemoprevention (SMC) is a main intervention to prevent and reduce childhood malaria. Since 2015, Guinea has implemented SMC targeting children aged 3–59 months (CU5) in districts with high and seasonal malaria transmission ...
Bisanzio D, Keita MS, Camara A, Guilavogui T, Diallo T, Barry H, Preston A, Bangoura L, Mbounga E, Florey LS, Taton JL, Fofana A, Reithinger R.   +12 more
europepmc   +2 more sources